Suppr超能文献

美国阿尔茨海默病神经影像学研究中种族/族裔代表性的量化:一项系统综述。

Quantification of race/ethnicity representation in Alzheimer's disease neuroimaging research in the USA: a systematic review.

作者信息

Lim Aaron C, Barnes Lisa L, Weissberger Gali H, Lamar Melissa, Nguyen Annie L, Fenton Laura, Herrera Jennifer, Han S Duke

机构信息

Department of Family Medicine, Keck School of Medicine of USC, Alhambra, CA, USA.

Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.

出版信息

Commun Med (Lond). 2023 Jul 25;3(1):101. doi: 10.1038/s43856-023-00333-6.

Abstract

BACKGROUND

Racial and ethnic minoritized groups are disproportionately at risk for Alzheimer's Disease (AD), but are not sufficiently recruited in AD neuroimaging research in the United States. This is important as sample composition impacts generalizability of findings, biomarker cutoffs, and treatment effects. No studies have quantified the breadth of race/ethnicity representation in the AD literature.

METHODS

This review identified median race/ethnicity composition of AD neuroimaging US-based research samples available as free full-text articles on PubMed. Two types of published studies were analyzed: studies that directly report race/ethnicity data (i.e., direct studies), and studies that do not report race/ethnicity but used data from a cohort study/database that does report this information (i.e., indirect studies).

RESULTS

Direct studies (n = 719) have median representation of 88.9% white or 87.4% Non-Hispanic white, 7.3% Black/African American, and 3.4% Hispanic/Latino ethnicity, with 0% Asian American, Native Hawaiian/Pacific Islander, and American Indian/Alaska Native, Multiracial, and Other Race participants. Cohort studies/databases (n = 44) from which indirect studies (n = 1745) derived are more diverse, with median representation of 84.2% white, 83.7% Non-Hispanic white, 11.6% Black/African American, 4.7% Hispanic/Latino, and 1.75% Asian American participants. Notably, 94% of indirect studies derive from just 10 cohort studies/databases. Comparisons of two time periods using a median split for publication year, 1994-2017 and 2018-2022, indicate that sample diversity has improved recently, particularly for Black/African American participants (3.39% from 1994-2017 and 8.29% from 2018-2022).

CONCLUSIONS

There is still underrepresentation of all minoritized groups relative to Census data, especially for Hispanic/Latino and Asian American individuals. The AD neuroimaging literature will benefit from increased representative recruitment of ethnic/racial minorities. More transparent reporting of race/ethnicity data is needed.

摘要

背景

种族和少数族裔群体患阿尔茨海默病(AD)的风险不成比例地高,但在美国的AD神经影像学研究中,这些群体的招募不足。这一点很重要,因为样本构成会影响研究结果的普遍性、生物标志物临界值和治疗效果。尚无研究对AD文献中种族/族裔代表性的广度进行量化。

方法

本综述确定了可在PubMed上获取的免费全文文章中基于美国的AD神经影像学研究样本的种族/族裔构成中位数。分析了两种已发表的研究类型:直接报告种族/族裔数据的研究(即直接研究),以及未报告种族/族裔但使用了报告该信息的队列研究/数据库数据的研究(即间接研究)。

结果

直接研究(n = 719)中,白人或非西班牙裔白人的构成中位数分别为88.9%或87.4%,黑人/非裔美国人占7.3%,西班牙裔/拉丁裔占3.4%,亚裔美国人、夏威夷原住民/太平洋岛民、美洲印第安人/阿拉斯加原住民、多种族和其他种族参与者的比例为0%。间接研究(n = 1745)所源自的队列研究/数据库(n = 44)则更多样化,白人的构成中位数为84.2%,非西班牙裔白人为83.7%,黑人/非裔美国人为11.6%,西班牙裔/拉丁裔为4.7%,亚裔美国人为1.75%。值得注意的是,94%的间接研究仅源自10个队列研究/数据库。对1994 - 2017年和2018 - 2022年这两个时间段按出版年份中位数进行划分后的比较表明,样本多样性最近有所改善,尤其是黑人/非裔美国参与者(1994 - 2017年为3.39%,2018 - 2022年为8.29%)。

结论

相对于人口普查数据,所有少数族裔群体的代表性仍然不足,尤其是西班牙裔/拉丁裔和亚裔美国人。AD神经影像学文献将受益于增加对少数族裔的代表性招募。需要更透明地报告种族/族裔数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cd5/10368705/5579bd76e716/43856_2023_333_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验